Inhibition of fatty acid synthase by amentoflavone suppresses HER2/neu (erbB2) oncogene expression in breast cancer cells

被引：0
|
作者：
Chang, E. [1 ,2 ]
Lee, J. [3 ]
Lee, M. [4 ]
Cha, E. [4 ]
Sul, J. [1 ,2 ]
Byun, W. [3 ]
机构：
[1] Chungnam Natl Univ, Sch Med, Dept Surg, Taejon, South Korea
[2] Chungnam Natl Univ, Res Inst Med Sci, Taejon, South Korea
[3] Chungnam Natl Univ Hosp, Dept Surg, Taejon, South Korea
[4] Chungnam Natl Univ Hosp, Reg Canc Inst, Taejon, South Korea
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(10)70442-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [21] Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells
    Marcus, Elizabeth A.
    Tokhtaeva, Elmira
    Turdikulova, Shahlo
    Capri, Joseph
    Whitelegge, Julian P.
    Scott, David R.
    Sachs, George
    Berditchevski, Fedor
    Vagin, Olga
    BIOCHEMICAL JOURNAL, 2016, 473 : 1703 - 1718
  • [22] Tucatinib HER2 (ErbB2) inhibitor Treatment of breast and colorectal cancer
    Patil, T.
    Shagisultanova, E.
    Borges, V. F.
    DRUGS OF THE FUTURE, 2019, 44 (01) : 11 - 19
  • [23] COMPLETE - Study the ErbB2 (HER2) - positive Breast cancer.
    Arnheim, Katharina
    Aktas, Bahriye
    ONKOLOGIE, 2010, 33 (04):
  • [24] ErbB2/HER2/Neu resembles an autoinhibited invertebrate EGF receptor
    Alvarado, Diego
    Klein, Daryl E.
    Lemmon, Mark A.
    FASEB JOURNAL, 2009, 23
  • [25] ErbB2 (HER2)-positives MammakarzinomResistenzmechanismenErbB2 (HER2) positive breast cancer Mechanisms of resistance
    K. Kast
    W. Distler
    Der Gynäkologe, 2010, 43 (7): : 574 - 578
  • [26] Inhibition of ErbB2(Her2) expression with small molecule transcription factor mimics
    Lee, Lori W.
    Taylor, Christopher E. C.
    Desaulniers, Jean-Paul
    Zhang, Manchao
    Hojfeldt, Jonas W.
    Pan, Quintin
    Mapp, Anna K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (21) : 6233 - 6236
  • [27] Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells
    Youngren, JF
    Gable, K
    Penaranda, C
    Maddux, BA
    Zavodovskaya, M
    Lobo, M
    Campbell, M
    Kerner, J
    Goldfine, ID
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 (01) : 37 - 46
  • [28] Nordihydroguaiaretic Acid (NDGA) Inhibits the IGF-1 and c-erbB2/HER2/neu Receptors and Suppresses Growth in Breast Cancer Cells
    Jack F. Youngren
    Karissa Gable
    Cristina Penaranda
    Betty A. Maddux
    Marianna Zavodovskaya
    Margaret Lobo
    Michael Campbell
    John Kerner
    Ira D. Goldfine
    Breast Cancer Research and Treatment, 2005, 94 : 37 - 46
  • [29] HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
    Plum, Patrick Sven
    Gebauer, Florian
    Kraemer, Max
    Alakus, Hakan
    Berlth, Felix
    Chon, Seung-Hun
    Schiffmann, Lars
    Zander, Thomas
    Buettner, Reinhard
    Hoelscher, Arnulf Heinrich
    Bruns, Christiane Josephine
    Quaas, Alexander
    Loeser, Heike
    BMC CANCER, 2019, 19 (1)
  • [30] When Tumor Suppressor TGFβ Meets the HER2 (ERBB2) Oncogene
    Chow, Amy
    Arteaga, Carlos L.
    Wang, Shizhen Emily
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2011, 16 (02) : 81 - 88
12345